Category: Drug Discovery
Drug Discovery market research reports by DelveInsight
-
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist - Pipeline Insight, 2025
“Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Transient Receptor ... Read More
-
Bullous Keratopathy - Market Insights, Epidemiology, and Market Forecast - 2034
Key Highlights According to DelveInsight’s estimates, in 2023, there were approximately 192 thousand diagnosed Bullous Keratopathy prevalent cases in the 7MM. Of these, the United States accounted for 41% of the cases, while Germany and Japan represented 13% and 9% of the cases, respectively. The bu ... Read More
-
TGF-Beta-2 Inhibitor - Pipeline Insight, 2025
“TGF-Beta-2 Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across TGF-Beta-2 Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechan ... Read More
-
Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2025
“Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor development. The report ... Read More
-
Selectin Inhibitor - Pipeline Insight, 2025
“Selectin Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Selectin Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s - Pipeline Insight, 2025
“Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s development. The ... Read More
-
Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2025
DelveInsight’s, “Interleukin-2 (IL-2) Inhibitor - Pipeline Insight, 2025” report provides comprehensive insights about 8+ companies and 10 pipeline drugs in Interleukin-2 (IL-2) Inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More
-
G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2025
“G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across G-Protein Coupled Receptor (GPCR) Agonist development. The report provides detailed coverage ... Read More
-
ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor - Pipeline Insight, 2025
“ATP Binding Cassette Sub Family B member 1 (ABCB1 or P-Glycoprotein or P-gp) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across ATP Binding Cassette Sub Family B member 1 (ABC ... Read More
-
Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2025
“Angiotensin Converting Enzyme (ACE) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Converting Enzyme (ACE) Inhibitor development. The report provides detailed ... Read More
-
Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2025
“Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin II Receptor Type 2 (AT2 Receptor) Modulator development. The repor ... Read More
-
Androgen Antagonist - Pipeline Insight, 2025
“Androgen Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Androgen Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Androgen Agonist - Pipeline Insight, 2025
“Androgen Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Androgen Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
Alpha v Beta 5 Integrin Antagonist - Pipeline Insight, 2025
“Alpha v Beta 5 Integrin Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha v Beta 5 Integrin Antagonist development. The report provides detailed coverage of the pipeli ... Read More
-
Alpha Receptor Agonist - Pipeline Insight, 2025
“Alpha Receptor Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha Receptor Agonist development. The report provides detailed coverage of the pipeline landscape for this me ... Read More
-
Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025
“Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha 4 Beta 7 (A4b7) Integrin Inhibitor- development. The report provides detailed coverage ... Read More
-
Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2025
“Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist development. The rep ... Read More
-
Adrenergic Antagonist - Pipeline Insight, 2025
“Adrenergic Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adrenergic Antagonist development. The report provides detailed coverage of the pipeline landscape for this mech ... Read More
-
Adenosine A2A Receptor Agonist - Pipeline Insight, 2025
“Adenosine A2A Receptor Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2A Receptor Agonist development. The report provides detailed coverage of the pipeline lands ... Read More
-
Adenosine A2B Receptor Antagonist - Pipeline Insight, 2025
“Adenosine A2B Receptor Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2B Receptor Antagonist development. The report provides detailed coverage of the pipeline ... Read More
-
5-HT6 Antagonist - Pipeline Insight, 2025
“5-HT6 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT6 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
5-HT2 Antagonist - Pipeline Insight, 2025
“5-HT2 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
5-HT1D Agonist - Pipeline Insight, 2025
DelveInsight’s, “5-HT1D Agonist - Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in 5-HT1D Agonist pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ass ... Read More
-
Ulcerative Colitis - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The Ulcerative Colitis Market Size in the 7MM was around USD 8,400 Million in 2023. The Ulcerative Colitis Market is anticipated to witness a positive shift owing to better uptake of existing drugs, and raised awareness. Ulcerative Colitis treatment is complex and comprises the use of ... Read More
-
TCR Therapy- Pipeline Insight, 2025
DelveInsight’s, “TCR Therapy- Pipeline Insight, 2025” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in TCR Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessm ... Read More
Research Assistance
